FdaApplication
NDA 016774
Identifiers
- fda_app_no: NDA016774
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SERENTIL | MESORIDAZINE BESYLATE | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| SERENTIL | MESORIDAZINE BESYLATE | EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| SERENTIL | MESORIDAZINE BESYLATE | EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| SERENTIL | MESORIDAZINE BESYLATE | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
4 products